Publication Name	World Journal of Diabetes
Manuscript ID	94745
Country	Kuwait

Received	2024-03-24 13:51
Peer-Review Started	2024-03-24 13:51
To Make the First Decision
Return for Revision	2024-05-08 03:06
Revised	2024-05-20 05:32
Second Decision	2024-06-17 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-06-17 07:19
Articles in Press	2024-06-17 07:19
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-07-28 13:31
Publish the Manuscript Online	2024-08-27 15:11

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Biochemical Research Methods
Manuscript Type	Editorial
Article Title	MicroRNA-630: A potential guardian against inflammation in diabetic kidney disease
Manuscript Source	Invited Manuscript
All Author List	Ashraf Al Madhoun
ORCID	Author(s) ORCID Number Ashraf Al Madhoun http://orcid.org/0000-0001-8593-3878
Funding Agency and Grant Number	Funding Agency Grant Number Kuwait Foundation for the Advancement of Sciences and Dasman Diabetes Institute, Kuwait RACB-2021-007
Corresponding Author	Ashraf Al Madhoun, PhD, Academic Research, Senior Scientist, Department of Genetics and Bioinformatics, Dasman Diabetes Institute, Jassim AlBahar Street, Dasman 15400, Kuwait. ashraf.madhoun@dasmainstitute.org
Key Words	Diabetic kidney disease; MicroRNA; MicroRNA-630; Toll-like receptor 4; Inflammation
Core Tip	Wu et al identified microRNA-630 as a promising candidate for the management of diabetic kidney disease, exerting its protective effects through the regulation of toll-like receptor 4-mediated inflammatory pathways. Further research elucidating the precise molecular mechanisms underlying microRNA-630’s actions and its therapeutic potential is warranted, with the ultimate goal of developing targeted interventions to alleviate the burden of diabetic kidney disease and improve patient outcomes.
Publish Date	2024-08-27 15:11
Citation	<p>Al Madhoun A. MicroRNA-630: A potential guardian against inflammation in diabetic kidney disease. <i>World J Diabetes</i> 2024; 15(9): 1837-1841</p>
URL	https://www.wjgnet.com/1948-9358/full/v15/i9/1837.htm
DOI	https://dx.doi.org/10.4239/wjd.v15.i9.1837

Full Article (PDF)	WJD-15-1837-with-cover.pdf
Full Article (Word)	WJD-15-1837.docx
Manuscript File	94745_Auto_Edited-YJP.docx
Answering Reviewers	94745-answering-reviewers.pdf
Audio Core Tip	94745-audio.mp3
Conflict-of-Interest Disclosure Form	94745-conflict-of-interest-statement.pdf
Copyright License Agreement	94745-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	94745-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate	94745-non-native-speakers.pdf
Peer-review Report	94745-peer-reviews.pdf
Scientific Misconduct Check	94745-scientific-misconduct-check.png
Scientific Editor Work List	94745-scientific-editor-work-list.pdf
CrossCheck Report	94745-crosscheck-report.pdf